Founded by scientists from University of California, San Diego in 2017, Genemo is a biotech company focusing on developing and driving the commercialization of brand new RNA detection technologies.
Staffed by top scientists and engineers from around the world, Genemo has established two unique ultra-sensitive RNA detection platforms, complementary to each other. One is Mos-Seq Serum. It is an NGS-based RNA-seq technology that enables people to quantitatively measure gene expression information from only 7µL of serum samples. The other platform is Lucid RNA. It is an improved single-molecule FISH (fluorescence in situ hybridization) technology, capable of highly specific identification of RNA molecules at an extremely sensitive level.
Supporting its ambitious vision, Genemo’s development team comprises a diverse set of talented individuals from backgrounds ranging from molecular biology, genetics, computer sciences, physics and electrical engineering. The board members and advisors come from academia and industry, each with a distinguished record. The work culture is founded on Genemo’s core values of innovation, collaboration, responsibility, and openness.